HANSOH PHARMAC. HD-00001

Research HANSOH PHARMAC. HD-00001 (3KY) on Bullrun: market cap EUR 19.03B, P/E 26.2, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker3KY
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 19.03B
• P/E26.2
• Dividend yield1.5%
• Financial periodFY2025
• RevenueEUR 15.03B
• Revenue growth22.6%
• Net incomeEUR 5.56B
• Free cash flowEUR 6.25B
• Gross margin90.0%

Valuation Snapshot

latest market cap is EUR 19.03B; P/E is 26.2; dividend yield is 1.5%.

About HANSOH PHARMAC. HD-00001

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan;

Frequently asked questions

What is HANSOH PHARMAC. HD-00001's market cap?

HANSOH PHARMAC. HD-00001's market capitalization is EUR 19.03B.

What is HANSOH PHARMAC. HD-00001's P/E ratio?

HANSOH PHARMAC. HD-00001's price-to-earnings (P/E) ratio is 26.2.

Does HANSOH PHARMAC. HD-00001 pay a dividend?

HANSOH PHARMAC. HD-00001 has a dividend yield of 1.5%.

What does HANSOH PHARMAC. HD-00001 do?

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China.